SNX3: Phosphoinositide-binding protein required for multivesicular body formation. Specifically binds phosphatidylinositol 3-phosphate (PtdIns(P3)). Plays a role in protein transport between cellular compartments. Promotes stability and cell surface expression of epithelial sodium channel (ENAC) subunits SCNN1A and SCNN1G. Not involved in EGFR degradation. A chromosomal aberration involving SNX3 may be a cause of microphthalmia syndromic type 8 (MCOPS8). Translocation t(6;13)(q21;q12). Microphthalmia is a clinically heterogeneous disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities. MCOPS8 is a very rare congenital syndrome characterized by microcephaly, microphthalmia, ectrodactyly of the lower limbs and prognathism. Intellectual deficit has been reported. Belongs to the sorting nexin family. 4 isoforms of the human protein are produced by alternative splicing.
Protein type: Vesicle
Chromosomal Location of Human Ortholog: 6q21
Cellular Component: extrinsic to membrane; intracellular membrane-bound organelle; clathrin-coated vesicle; retromer complex; early endosome membrane; cytoplasm; early endosome; endosome membrane; cytosol
Molecular Function: protein binding; phosphatidylinositol-5-phosphate binding; protein phosphatase binding; phosphatidylinositol 3-phosphate binding
Biological Process: hemoglobin biosynthetic process; negative regulation of phagocytosis; regulation of cellular protein metabolic process; regulation of intracellular protein transport; response to bacterium; negative regulation of virion penetration into host cell; vesicle organization and biogenesis; regulation of Wnt receptor signaling pathway; membrane invagination; transferrin transport; protein to membrane docking; negative regulation of protein transport; negative regulation of protein catabolic process
Disease: Microphthalmia, Syndromic 8
Show more